Harvey D. White
About
In The Last Decade
Harvey D. White
689 papers receiving 55.7k citations
Hit Papers
Peers
Comparison fields: 5 of 193
- Cardiology and Cardiovascular Medicine 45.2k
- Surgery 21.6k
- Radiology, Nuclear Medicine and Imaging 14.0k
- Internal Medicine 5.8k
- Pulmonary and Respiratory Medicine 4.2k
Countries citing papers authored by Harvey D. White
This map shows the geographic impact of Harvey D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey D. White more than expected).
Fields of papers citing papers by Harvey D. White
This network shows the impact of papers produced by Harvey D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey D. White. The network helps show where Harvey D. White may publish in the future.
Co-authorship network of co-authors of Harvey D. White
This figure shows the co-authorship network connecting the top 25 collaborators of Harvey D. White. A scholar is included among the top collaborators of Harvey D. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey D. White. Harvey D. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 86 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 11 | |
| 7 | 25 | |
| 8 | 82 | |
| 9 | 30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18). | 5 |
| 10 | A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012. | 3 |
| 11 | The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9). | 38 |
| 12 | 19 | |
| 13 | 22 | |
| 14 | 1 | |
| 15 | Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. | 12 |
| 16 | ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. | 12 |
| 17 | Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction | 3 |
| 18 | PHARMAC and lack of funding for clopidogrel. | 2 |
| 19 | 0 | |
| 20 | Management of acute myocardial infarction in Auckland. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.